Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients

Clinical Transplantation

Volumn 24, Issue 5, 2010, Pages 652-659

  Kamphues, Carsten ^a   Lotz, Katharina ^a   Röcken, Christoph ^a   Berg, Thomas ^a   Eurich, Dennis ^a   Pratschke, Johann ^a   Neuhaus, Peter ^a   Neumann, Ulf P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcoholic cirrhosis; Hepatitis C; Liver fibrosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; FIB 4 INDEX; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGIDITY; TRANSIENT ELASTOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; ELASTICITY IMAGING TECHNIQUES; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77955261493     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01152.x     Document Type: Article

References (28)

1. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002: 36: 152.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001: 344: 495.
3. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008: 14: 3396.
4. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000: 14: 543.
5. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990: 99: 1396.
6. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003: 38: 1449.
7. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003: 38: 518.
8. Vallet-Pichard A, Mallet V, Nalpas B et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest. Hepatology 2007: 46: 32.
9. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999: 6: 35.
10. Niederau C, Lange S, Heintges T et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998: 28: 1687.
11. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003: 29: 1705.
12. Yeshua H, Oren R. Non invasive assessment of liver fibrosis. Ann Transplant 2008: 13: 5.
13. Tatsumi C, Kudo M, Ueshima K et al. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (Fibroscan) and real-time tissue elastography. Intervirology 2008: 51: 27.
14. Corradi F, Piscaglia F, Flori S et al. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis 2009 Mar; 41(3): 217-25. Epub 2008 Jul 30.
15. Yoshioka K, Kawabe N, Hashimoto S. Transient elastography: applications and limitations. Hepatol Res 2008 Nov; 38(11): 1063-8. Epub 2008 Jun 19.
16. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005: 128: 343.
17. Ganne-Carrie N, Ziol M, De Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006: 44: 1511.
18. Berenguer M, Wright TL. Hepatitis C and liver transplantation. Gut 1999: 45: 159.
19. Neumann UP, Berg T, Bahra M et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004: 41: 830.
20. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991: 13: 372.
21. Berenguer M, Palau A, Fernandez A et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2006: 12: 1067.
22. Gane EJ, Portmann BC, Naoumov NV et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996: 334: 815.
23. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006: 12: 1791.
24. Rigamonti C, Donato MF, Fraquelli M et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 2008: 57: 821.
25. Harada N, Soejima Y, Taketomi A et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008: 85: 69.
26. Poynard T, Munteanu M, Imbert-Bismut F et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004: 50: 1344.
27. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002: 97: 2614.
28. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994: 20: 15.